$3.26
-0.04-1.21%
al cierre: -
$3.26
0.000.00%
After hour: Oct 24, 4:00 PM EDT
Comments
Loading...
CytomX Therapeutics Actividad de operaciones con información privilegiada
CTMXNASDAQ
Actividad de operaciones de insiders
Sigue la actividad de operaciones con información privilegiada más reciente de CytomX Therapeutics. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de CytomX Therapeutics.
¿Qué es la actividad interna?
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
¿Qué están haciendo CytomX Therapeutics Inc los iniciados?
Los expertos no han informado de compras ni ventas en los últimos 30 días.
Compras y ventas recientes notables de información privilegiada
No ha habido ninguna compra o venta de información privilegiada en los últimos 90 días.
Estadísticas de propiedad de CytomX Therapeutics Inc
Acciones en circulación
164.913M
Acciones en manos de personas con información privilegiada
2.489M
Porcentaje de acciones en manos de personas con información privilegiada
1.51%
Acciones en manos de instituciones
27.516M
Porcentaje de acciones en manos de instituciones
16.7%
Jun 17, 2025 | CHIEF FINANCIAL OFFICER | 25.25K | $2.72 | -$33.38K | SELL-OPTIONS | 12.56% | 226.27K | Jun 13 - Jun 16 | ||
Jun 17, 2025 | SVP, CHIEF SCIENTIFIC OFFICER | 23.62K | $2.69 | -$37.33K | SELL-OPTIONS | 9.50% | 272.25K | Jun 13 - Jun 16 | ||
Jun 17, 2025 | CEO | 94.49K | $2.69 | -$149.26K | SELL-OPTIONS | 8.68% | 1.18M | Jun 13 - Jun 16 | ||
Mar 20, 2025 | CEO | -37.66K | $0.60 | -$22.56K | SELL | -3.34% | 1.09M | Mar 18 | ||
Mar 20, 2025 | CHIEF FINANCIAL OFFICER | -8.55K | $0.60 | -$5.12K | SELL | -4.08% | 201.03K | Mar 18 | ||
Mar 20, 2025 | CHIEF MEDICAL OFFICER | -4.03K | $0.60 | -$2.41K | SELL | -2.88% | 135.72K | Mar 18 | ||
Mar 20, 2025 | GENERAL COUNSEL | -10.20K | $0.60 | -$6.11K | SELL | -7.80% | 120.59K | Mar 18 | ||
Mar 20, 2025 | SVP, CHIEF SCIENTIFIC OFFICER | -19.51K | $0.60 | -$11.69K | SELL | -7.28% | 248.64K | Mar 18 | ||
Aug 22, 2024 | CHIEF BUSINESS OFFICER | 7.07K | $1.23 | -$5.14K | SELL-OPTIONS | 6.14% | 122.24K | Aug 20 | ||
Aug 22, 2024 | SVP, CHIEF SCIENTIFIC OFFICER | 7.07K | $1.23 | -$5.14K | SELL-OPTIONS | 4.19% | 175.65K | Aug 20 | ||
Aug 22, 2024 | GENERAL COUNSEL | 7.07K | $1.23 | -$5.14K | SELL-OPTIONS | 5.71% | 130.80K | Aug 20 | ||
Aug 22, 2024 | CHIEF FINANCIAL OFFICER | 4.89K | $1.23 | -$2.44K | SELL-OPTIONS | 4.74% | 108.08K | Aug 20 | ||
Aug 22, 2024 | CEO | 23.60K | $1.23 | -$17.08K | SELL-OPTIONS | 3.24% | 751.01K | Aug 20 | ||
Mar 21, 2024 | GENERAL COUNSEL | -5.27K | $2.09 | -$10.99K | SELL | -4.28% | 117.73K | Mar 19 | ||
Mar 21, 2024 | CEO | -20.22K | $2.09 | -$42.18K | SELL | -3.17% | 617.64K | Mar 19 | ||
Mar 21, 2024 | SVP, FINANCE AND ACCOUNTING | -2.97K | $2.09 | -$6.20K | SELL | -3.35% | 85.69K | Mar 19 | ||
Mar 21, 2024 | SVP, CHIEF SCIENTIFIC OFFICER | -12.79K | $2.09 | -$26.68K | SELL | -7.05% | 168.58K | Mar 19 | ||
Mar 21, 2024 | CHIEF BUSINESS OFFICER | -6.56K | $2.09 | -$13.69K | SELL | -5.48% | 113.24K | Mar 19 | ||
Dec 22, 2023 | CEO | -13.55K | $1.38 | -$18.71K | SELL | -2.41% | 547.86K | Dec 20 | ||
Dec 22, 2023 | SVP, CHIEF SCIENTIFIC OFFICER | -4.08K | $1.38 | -$5.63K | SELL | -2.56% | 155.12K | Dec 20 | ||
Dec 22, 2023 | CHIEF BUSINESS OFFICER | -4.08K | $1.38 | -$5.63K | SELL | -4.34% | 89.80K | Dec 20 | ||
Dec 22, 2023 | GENERAL COUNSEL | -4.08K | $1.38 | -$5.63K | SELL | -3.99% | 98.00K | Dec 20 | ||
Dec 22, 2023 | SVP, FINANCE AND ACCOUNTING | -1.99K | $1.38 | -$2.75K | SELL | -3.93% | 48.66K | Dec 20 | ||
Sep 22, 2023 | SVP, CHIEF SCIENTIFIC OFFICER | 7.13K | $1.30 | -$5.36K | GRANT | 5.06% | 147.95K | Sep 20 - Sep 22 | ||
Sep 22, 2023 | CHIEF BUSINESS OFFICER | 7.13K | $1.30 | -$5.36K | GRANT | 9.85% | 79.56K | Sep 20 - Sep 22 | ||
Sep 22, 2023 | CEO | 25.40K | $1.30 | -$18.99K | GRANT | 5.09% | 523.91K | Sep 20 - Sep 22 | ||
Sep 22, 2023 | GENERAL COUNSEL | 9.51K | $1.30 | -$7.14K | GRANT | 13.38% | 80.61K | Sep 20 - Sep 22 | ||
Mar 31, 2023 | — | 5.00K | $1.55 | $7.75K | BUY | 3521.13% | 5.14K | Mar 29 | ||
Mar 20, 2023 | SVP, FINANCE AND ACCOUNTING | -516.00 | $1.98 | -$1.02K | SELL | -1.35% | 37.77K | Mar 16 | ||
Mar 20, 2023 | CHIEF FINANCIAL OFFICER | -1.75K | $1.98 | -$3.46K | SELL | -4.37% | 38.22K | Mar 16 | ||
Mar 20, 2023 | CEO | -7.12K | $1.88 | -$13.39K | SELL | -1.46% | 481.98K | Mar 16 | ||
Mar 20, 2023 | GENERAL COUNSEL | -2.04K | $1.98 | -$4.03K | SELL | -2.79% | 71.09K | Mar 16 | ||
Mar 20, 2023 | CHIEF FINANCIAL OFFICER | -1.48K | $1.98 | -$2.92K | SELL | -2.00% | 72.43K | Mar 16 | ||
Mar 20, 2023 | EVP, CHIEF DEVELOPMENT OFFICER | -4.26K | $1.98 | -$8.42K | SELL | -6.79% | 58.43K | Mar 16 | ||
Jul 21, 2022 | EVP, CHIEF DEVELOPMENT OFFICER | 12.54K | $1.42 | -$10.61K | GRANT | 25.00% | 62.69K | Jul 19 - Jul 20 | ||
Jul 21, 2022 | CHIEF BUSINESS OFFICER | 7.04K | $1.42 | -$5.98K | GRANT | 26.22% | 33.91K | Jul 19 - Jul 20 | ||
Jul 21, 2022 | PRESIDENT AND CEO | 25.09K | $1.42 | -$21.21K | GRANT | 6.99% | 384.10K | Jul 19 - Jul 20 | ||
Jul 21, 2022 | GENERAL COUNSEL | 9.40K | $1.42 | -$7.97K | GRANT | 27.41% | 43.69K | Jul 19 - Jul 20 | ||
Jul 21, 2022 | CHIEF MEDICAL OFFICER | 9.40K | $1.42 | -$7.97K | GRANT | 41.77% | 31.90K | Jul 19 - Jul 20 | ||
Jul 21, 2022 | CHIEF FINANCIAL OFFICER | 11.05K | $1.42 | -$5.62K | GRANT | 38.21% | 39.97K | Jul 19 - Jul 20 | ||
Jun 21, 2021 | PRESIDENT AND CEO | -100.00K | $7.04 | -$704.47K | SELL | -49.76% | 100.97K | Jun 16 | ||
Apr 02, 2021 | PRESIDENT AND CEO | 0.00 | $4.31 | -$636.08K | SELL-OPTIONS | 0.00% | 206.89K | Mar 31 |
PREGUNTAS FRECUENTES
¿Es legal el uso de información privilegiada?
Las operaciones con información privilegiada son legales siempre que se notifiquen a la Comisión de Bolsa y Valores (SEC). El comercio ilegal de valores se produce cuando la persona con información privilegiada viola un deber fiduciario o no informa de sus operaciones.
¿Cuáles son algunos ejemplos de manipulación del mercado?
Las operaciones con información privilegiada, los esquemas de pump and dump, el front running y las operaciones de lavado son ejemplos de manipulación del mercado. Los inversores que siguen el movimiento de activos con información privilegiada deben pensar atentamente por qué estos operadores con información privilegiada están negociando sus acciones antes de seguir adelante.
Explora operaciones con información privilegiada sobre todos los valores.